BioSapien Extends Pre-Series A Round to $7M to Advance Localised Cancer Treatment
UAE-based healthtech company BioSapien has extended its pre-Series A round to $7 million, welcoming new investment from Golden Gate Ventures, marking the first deployment from its dedicated MENA Fund. This […]